Skip to main content

Table 5 Comparison of laboratory findings of acute phase reaction in three visits

From: Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever – a randomized controlled noninferiority trial

 

Once-daily dosage group (n = 42)

Twice-daily dosage group (n = 37)

 

Baseline

First visit

Second visit

Baseline

First visit

Second visit

p Valuea

Leukocytosis, %

11.9

4.8

4.8

8.1

2.7

5.4

0.591

Thrombocytosis, %

4.8

2.4

4.8

5.4

2.7

10.8

0.329

High ESR, %

55.9

12.5

4.2

56.7

22.2

0

0.988

Elevated CRP, %

40.5

21.4

14.3

37.8

13.5

10.8

0.435

SAA,b mg/L

4.86 ± 3.73

 

3.28 ± 3.40

4.70 ± 3.57

 

3.28 ± 3.46

0.449

  1. CRP C-reactive protein, ESR erythrocyte sedimentation rate, SAA serum amyloid A
  2. a p value for intergroup comparison of laboratory results
  3. bMean ± SD
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us